CLINICAL
Abstract
er vo ric ear HER2, and proliferation. Adjuvant endocrine therapy for a minimum of five years postoperatively is advised to pa-differ molecularly, in prognosis as well as relapse rates after different therapy modalities [4]. The two lumina